You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

selumetinib

Showing 26 - 50 of 50
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC (NSCLC) Trial in Tainan, Taipei (selumetinib)

Completed
  • Non-small Cell Lung Cancer (NSCLC)
  • selumetinib
  • Tainan, Taiwan
  • +2 more
Jul 9, 2018

Malignant Tumor of Respiratory and Intrathoracic Organ Carcinoma, Advanced Lung Cancer, Recurrent Nonsmall Cell Lung Cancer

Withdrawn
  • Malignant Neoplasm of Respiratory and Intrathoracic Organ Carcinoma
  • +2 more
  • Selumetinib
  • +2 more
  • (no location specified)
Mar 14, 2018

Breast Cancer Trial in Belgium, Switzerland (fulvestrant, selumetinib)

Completed
  • Breast Cancer
  • Ghent, Belgium
  • +16 more
May 13, 2019

Locally Advanced or Metastatic NSCL Cancer Stage IIIB IV Trial in United Kingdom (selumetinib, gemcitabine, cisplatin)

Completed
Has Results
  • Locally Advanced or Metastatic NSCL Cancer Stage IIIB IV
  • selumetinib
  • +4 more
  • Glasgow, United Kingdom
  • +3 more
Mar 12, 2018

Recurrent Thyroid Gland Carcinoma, Stage I Thyroid Gland Papillary Carcinoma, Stage II Thyroid Gland Papillary Carcinoma Trial

Completed
Has Results
  • Recurrent Thyroid Gland Carcinoma
  • +4 more
  • Laboratory Biomarker Analysis
  • Selumetinib
  • Tampa, Florida
  • +5 more
Dec 2, 2016

Iris Melanoma, Medium/Large Size Posterior Uveal Melanoma, Ocular Melanoma With Extraocular Extension Trial in Canada, United

Completed
Has Results
  • Iris Melanoma
  • +5 more
  • Aurora, Colorado
  • +32 more
Jun 26, 2017

Inoperable Locally Advanced or Metastatic Biliary Tract Cancer Trial in Kashiwa Shi, Chuo Ku (Cisplatin, Gemcitabine,

Terminated
Has Results
  • Inoperable Locally Advanced or Metastatic Biliary Tract Cancer
  • Kashiwa Shi, Chiba, Japan
  • +1 more
May 5, 2016

Biliary Tract Tumors, Cholangiocarcinoma, Gallbladder Tumors Trial in London, Manchester (selumetinib, gemcitabine, cisplatin)

Completed
  • Biliary Tract Neoplasms
  • +2 more
  • selumetinib
  • +2 more
  • London, United Kingdom
  • +2 more
May 11, 2016

Liver and Intrahepatic Biliary Tract Cancer, Recurrent Extrahepatic Bile Duct Cancer, Unresectable Extrahepatic Bile Duct Cancer

Completed
Has Results
  • Liver and Intrahepatic Biliary Tract Cancer
  • +2 more
  • selumetinib
  • laboratory biomarker analysis
  • Tampa, Florida
  • +6 more
Mar 22, 2016

Adult Solid Tumor Trial in Baltimore (biological, other, drug)

Completed
  • Adult Solid Neoplasm
  • Cixutumumab
  • +3 more
  • Baltimore, Maryland
    Johns Hopkins University/Sidney Kimmel Cancer Center
Jan 22, 2016

Adult Solid Tumor Trial in Boston, Charlestown, New York (Selumetinib)

Completed
Has Results
  • Adult Solid Neoplasm
  • Selumetinib
  • Boston, Massachusetts
  • +4 more
Dec 10, 2015

Solid Tumours Trial in Overland Park (Selumetinib, Moxifloxacin, selumetinib )

Completed
Has Results
  • Solid Tumours
  • Selumetinib
  • +2 more
  • Overland Park, Kansas
    Research Site
Oct 7, 2015

Recurrent Adult Diffuse Large Cell Lymphoma Trial in United States (Laboratory Biomarker Analysis, Selumetinib)

Terminated
Has Results
  • Recurrent Adult Diffuse Large Cell Lymphoma
  • Laboratory Biomarker Analysis
  • Selumetinib
  • Chicago, Illinois
  • +15 more
Jan 4, 2016

Solid Tumours Trial in Overland Park (selumetinib, itraconazole, fluconazole)

Completed
  • Solid Tumours
  • selumetinib
  • +2 more
  • Overland Park, Kansas
    Research Site
Jun 29, 2015

Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma Trial in United

Completed
Has Results
  • Recurrent Adult Soft Tissue Sarcoma
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Beverly Hills, California
  • +7 more
Sep 4, 2015

Solid Tumours Trial in Orlando (selumetinib)

Completed
  • Solid Tumours
  • selumetinib
  • Orlando, Florida
    Research Site
Jun 29, 2015

Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Promyelocytic Leukemia (M3), MDS Trial in Chicago (selumetinib)

Completed
Has Results
  • Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)
  • +5 more
  • selumetinib
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Jul 6, 2015

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in United States (Laboratory Biomarker Analysis,

Completed
Has Results
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Laboratory Biomarker Analysis
  • Selumetinib
  • Tampa, Florida
  • +8 more
Jul 24, 2015

Recurrent Melanoma, Stage III Skin Melanoma, Stage IV Skin Melanoma Trial in New York (Laboratory Biomarker Analysis,

Completed
Has Results
  • Recurrent Melanoma
  • +2 more
  • Laboratory Biomarker Analysis
  • Selumetinib
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jul 16, 2015

Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma, Recurrent Pancreatic Carcinoma Trial in United States (Akt

Completed
Has Results
  • Pancreatic Acinar Cell Carcinoma
  • +3 more
  • Akt Inhibitor MK2206
  • +3 more
  • Tucson, Arizona
  • +533 more
Feb 10, 2016

Healthy Volunteers Pharmacokinetic Study Trial in London (Selumetinib)

Completed
  • Healthy Volunteers Pharmacokinetic Study
  • Selumetinib
  • London, United Kingdom
    Research Site
May 30, 2014

Solid Tumours Trial in Overland Park (selumetinib, rifampicin)

Completed
  • Solid Tumours
  • Overland Park, Kansas
    Research Site
Apr 28, 2014

Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma Trial in United States (Akt inhibitor MK2206, selumetinib,

Terminated
Has Results
  • Recurrent Melanoma
  • +4 more
  • Akt inhibitor MK2206
  • +2 more
  • Atlanta, Georgia
  • +3 more
May 16, 2014

Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer

Completed
Has Results
  • Adult Primary Hepatocellular Carcinoma
  • +3 more
  • selumetinib
  • pharmacological study
  • Tampa, Florida
  • +5 more
May 12, 2014

Mucosal Melanoma, Recurrent Melanoma, Stage IV Melanoma Trial in Tampa (temsirolimus, selumetinib, laboratory biomarker

Terminated
Has Results
  • Mucosal Melanoma
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Apr 29, 2014